Skip to main content

Table 1 Patient characteristics

From: Cone beam CT-based dose accumulation and analysis of delivered dose to the dominant intraprostatic lesion in primary radiotherapy of prostate cancer

Characteristics

Median age in years (range)

71 (57–83)

Median KPS in % (range)

100 (70–100)

Median iPSA in ng/mL (range)

7.9 (3.3–25.4)

Median DIL volume in cm3 (range)

1.4 (0.4–6.6)

Gleason score

 6

5 (21.7%)

 7

13 (56.5%)

 8–10

5 (21.7%)

TNM stage

 cT1a-c

21 (91.3%)

 cT2a-c

2 (8.7%)

D’Amico risk group

 Low-risk

5 (21.7%)

 Intermediate-risk

11 (47.8%)

 High-risk

7 (30.4%)

Index lesion sector distribution

 Anterior fibromuscular stroma

8/23 (34.8%)

 Anterior TZ

6/23 (26.1%)

 Posterior TZ

5/23 (21.7%%)

 Anterior PZ

2/23 (8.7%)

 Posterior medial PZ

8/23 (34.8%)

 Posterior lateral PZ

11/23 (47.8%)

 Central zone

0/23 (0.0%)

  1. KPS Karnofsky Performance Status, iPSA initial prostate-specific antigen, DIL dominant intraprostatic lesion, TZ transition zone, PZ peripheral zone